收稿日期: 2020-07-22
网络出版日期: 2021-10-11
基金资助
福建省自然科学基金(2017J01170);福建省自然科学基金(2019J01184)
吴燕芳 , 高飞 , 林滇恬 , 陈志涵 , 林禾 . 托法替布联合治疗抗MDA5抗体阳性的无肌病皮肌炎并发快速进展型间质性肺病5例临床分析[J]. 北京大学学报（医学版）, 2021 , 53(5) : 1012 -1016 . DOI: 10.19723/j.issn.1671-167X.2021.05.034
| [1] | Nakashima R, Hosono Y, Mimori T. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease [J]. Lupus, 2016, 25(8):925-933. |
| [2] | 陈芳, 王冬雪, 舒晓明, 等. 血清抗黑色素瘤分化相关基因抗体检测在多发性肌炎/皮肌炎患者中的意义 [J]. 中华风湿病学杂志, 2012, 16(1):13-18. |
| [3] | Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyo-sitis-associated interstitial lung disease [J]. N Engl J Med, 2019, 381(3):291-293. |
| [4] | Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups [J]. Ann Rheum Dis, 2017, 76(12):1955-1964. |
| [5] | Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias [J]. Am J Respir Crit Care Med, 2013, 188(6):733-748. |
| [6] | Goldin JG, Lynch DA, Strollo DC, et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease [J]. Chest, 2008, 134(2):358-367. |
| [7] | 卢昕, 王国春. 重视新型肌炎特异性自身抗体的临床应用 [J]. 中华风湿病学杂志, 2015, 19(3):145-147. |
| [8] | Cao H, Pan M, Kang Y, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody [J]. Arthritis Care Res (Hoboken), 2012, 64(10):1602-1610. |
| [9] | Ye S, Chen XX, Lu XY, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: A retrospective cohort study [J]. Clin Rheumatol, 2007, 26(10):1647-1654. |
| [10] | Kurasawa K, Arai S, Namiki Y, et al. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis [J]. Rheumatology (Oxford), 2018, 57(12):2114-2119. |
| [11] | 许文英, 梅焕平. 生物制剂在多肌炎皮肌炎并发间质性肺病的治疗进展 [J]. 中华风湿病学杂志, 2016, 20(7):489-492. |
| [12] | 黄慧, 邵池, 徐作军. 美国胸科协会官方指南: 支气管肺泡灌洗液的细胞学分析在间质性肺疾病中的临床应用(摘译本) [J]. 中华结核和呼吸杂志, 2012, 35(9):650-654. |
| [13] | Kono M, Miyashita K, Hirama R, et al. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exa-cerbation of interstitial lung disease [J]. Respir Med, 2021, 186:106534. |
| [14] | Salonen J, Lampela H, Keskitalo E, et al. Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study [J]. Clin Immunol, 2020, 220:108594. |
| [15] | Xu Y, Yang CS, Li YJ, et al. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis [J]. Clin Rheumatol, 2016, 35(1):113-116. |
/
| 〈 |
|
〉 |
